Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
NCT05187884
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Ocular Melanoma
Interventions
DRUG:
Darovasertib
Sponsor
St Vincent's Hospital, Sydney